RICHARD M. MYERs, PHD

President, Science Director and Faculty Investigator | HudsonAlpha Institute for Biotechnology

 

As an early leader in human genome sequencing, Richard Myers, Ph.D. has spent more than 35 years using genetics and genomics to better understand how genes and their expression contribute to human diseases and other traits. As the founding president and science director, Myers leadership has built the HudsonAlpha Institute for Biotechnology into a genuinely unique institution focused on conducting genomics-based research to improve human health and well-being, implementing genomic medicine, sparking economic development and providing educational outreach to nurture the next generation of biotech researchers and entrepreneurs, as well as to create a life sciences-literate public.

Myers previously was professor and chair at the Department of Genetics at Stanford University School of Medicine, and directed the Stanford Human Genome Center, one of the first U.S. human genome centers. Under Myers’ direction, the Stanford Human Genome Center with the Joint Genome Institute contributed more than 10% of the data in the public Human Genome Project’s effort to sequence the first human genome.

In addition to providing strategic oversight for HudsonAlpha, Myers also sustains a large, active laboratory. The Myers Lab at HudsonAlpha studies the human genome, with a focus on allelic variation and how gene expression changes contribute to human traits, including disease. His group utilizes a number of high-throughput genomic methods, including DNA sequencing, genotyping, chromatin immunoprecipitation, mRNA expression profiling, transcriptional promoter and DNA methylation measurements. The lab also uses computational and statistical tools for identifying, characterizing and understanding how functional elements of the genome work together at the molecular level. Researchers in the Myers Lab use these and other state-of-the-art methods to explore how genomes are involved in neurodegenerative and neuropsychiatric disorders, cancer, children born with developmental disorders, autoimmune diseases and other traits.

In addition to his work at HudsonAlpha, Myers serves as Adjunct Professor, Department of Genetics, University of Alabama at Birmingham Medical Center and as Adjunct Professor, Department of Biological Sciences, University of Alabama in Huntsville. He serves on many advisory boards in academia, industry and government. Myers earned his B.S. in biochemistry from The University of Alabama and Ph.D. in biochemistry from the University of California at Berkeley, and did postdoctoral work at Harvard University.